Allred D Craig
Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Ave, Campus Box 8118, St Louis, MO 63110, USA.
J Natl Cancer Inst Monogr. 2010;2010(41):134-8. doi: 10.1093/jncimonographs/lgq035.
Ductal carcinoma in situ (DCIS) refers to breast epithelial cells that have become "cancerous" but still reside in their normal place in the ducts and lobules. In this setting, cancerous means that there is an abnormal increase in the growth of the epithelial cells, which accumulate within and greatly expand the ducts and lobules. DCIS is a nonlethal type of cancer because it stays in its normal place. However, DCIS is very important because it is the immediate precursor of invasive breast cancers, which are potentially lethal. This article provides a general overview of DCIS, including historical perspective, methods of classification, current perspective, and future goals.
导管原位癌(DCIS)是指乳腺上皮细胞已发生“癌变”,但仍位于导管和小叶的正常位置。在此情况下,癌变意味着上皮细胞生长异常增加,这些细胞在导管和小叶内积聚并使其显著扩张。DCIS是一种非致死性癌症,因为它停留在原位。然而,DCIS非常重要,因为它是浸润性乳腺癌的直接前体,而浸润性乳腺癌具有潜在致死性。本文对DCIS进行了概述,包括历史背景、分类方法、当前观点和未来目标。